Elizabeth Pisani

3.1k total citations
72 papers, 1.7k citations indexed

About

Elizabeth Pisani is a scholar working on Economics and Econometrics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elizabeth Pisani has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Economics and Econometrics, 16 papers in Epidemiology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elizabeth Pisani's work include Pharmaceutical Economics and Policy (15 papers), HIV/AIDS Research and Interventions (13 papers) and HIV, Drug Use, Sexual Risk (13 papers). Elizabeth Pisani is often cited by papers focused on Pharmaceutical Economics and Policy (15 papers), HIV/AIDS Research and Interventions (13 papers) and HIV, Drug Use, Sexual Risk (13 papers). Elizabeth Pisani collaborates with scholars based in Italy, United Kingdom and Netherlands. Elizabeth Pisani's co-authors include Carla AbouZahr, Maarten Kok, Peter D. Ghys, Carol Jenkins, Basia Żaba, Claudio Ronco, Mariano Feriani, S Biasioli, G. La Greca and P. L. Giorgi and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Elizabeth Pisani

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Pisani Italy 22 670 557 473 378 232 72 1.7k
Hala Ghattas Lebanon 28 250 0.4× 151 0.3× 222 0.5× 651 1.7× 100 0.4× 111 2.9k
Heather Brown United States 21 285 0.4× 619 1.1× 727 1.5× 1.3k 3.4× 116 0.5× 46 2.6k
Tim Brown United States 22 799 1.2× 925 1.7× 330 0.7× 409 1.1× 174 0.8× 49 1.6k
Douglas Johnson Australia 23 250 0.4× 262 0.5× 164 0.3× 185 0.5× 60 0.3× 103 1.7k
Alec Miners United Kingdom 28 1.3k 1.9× 1.2k 2.1× 251 0.5× 397 1.1× 324 1.4× 101 2.7k
Martin B Van Der Weyden Australia 25 342 0.5× 156 0.3× 46 0.1× 262 0.7× 118 0.5× 209 2.4k
Kevin L. Schwartz Canada 28 1.2k 1.8× 1.2k 2.2× 62 0.1× 423 1.1× 152 0.7× 132 3.6k
Joanne Yoong Singapore 26 366 0.5× 248 0.4× 225 0.5× 398 1.1× 1.0k 4.4× 139 2.9k
Howard Markel United States 26 473 0.7× 389 0.7× 362 0.8× 476 1.3× 292 1.3× 149 2.6k
Juan Pablo Gutiérrez Mexico 28 698 1.0× 741 1.3× 581 1.2× 882 2.3× 244 1.1× 106 2.4k

Countries citing papers authored by Elizabeth Pisani

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Pisani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Pisani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Pisani more than expected).

Fields of papers citing papers by Elizabeth Pisani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Pisani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Pisani. The network helps show where Elizabeth Pisani may publish in the future.

Co-authorship network of co-authors of Elizabeth Pisani

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Pisani. A scholar is included among the top collaborators of Elizabeth Pisani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Pisani. Elizabeth Pisani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pisani, Elizabeth, et al.. (2024). A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines. SHILAP Revista de lepidopterología. 4(12). e0003999–e0003999. 2 indexed citations
2.
Hauck, Katharina, et al.. (2024). Value for money of medicine sampling and quality testing: evidence from Indonesia. BMJ Global Health. 9(9). e015402–e015402. 3 indexed citations
3.
Pisani, Elizabeth, et al.. (2023). Why falsified medicines reach patients: an analysis of political and economic factors in Romania. BMJ Global Health. 6(Suppl 3). e009918–e009918. 10 indexed citations
4.
Pisani, Elizabeth, et al.. (2023). Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia. Journal of Pharmaceutical Policy and Practice. 16(1). 50–50. 3 indexed citations
5.
Patel, Anushka, Anna Palagyi, Devarsetty Praveen, et al.. (2022). A study of the quality of cardiovascular and diabetes medicines in Malang District, Indonesia, using exposure-based sampling. BMJ Global Health. 7(11). e009762–e009762. 6 indexed citations
6.
Pisani, Elizabeth, et al.. (2022). A systematic review of pooled procurement of medicines and vaccines: identifying elements of success. Globalization and Health. 18(1). 59–59. 30 indexed citations
7.
Aljuffali, Ibrahim A., Nahar Alazemi, Taghred Alghaith, et al.. (2022). National medicines policy development, Saudi Arabia. Bulletin of the World Health Organization. 100(8). 511–519. 4 indexed citations
8.
Pisani, Elizabeth, et al.. (2021). Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia. BMJ Global Health. 6(Suppl 3). e003663–e003663. 28 indexed citations
9.
Pisani, Elizabeth, et al.. (2021). Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance. JMIR Public Health and Surveillance. 7(8). e29309–e29309. 15 indexed citations
10.
11.
Alghaith, Taghred, Nahar Alazemi, Mohammed Alluhidan, et al.. (2020). Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia Towards a Medicine Policy to Support Vision 2030. The World Bank Open Knowledge Repository (World Bank). 1 indexed citations
12.
Pisani, Elizabeth, et al.. (2020). What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey. Global Health Science and Practice. 8(3). 431–441. 16 indexed citations
13.
14.
Pisani, Elizabeth & Maarten Kok. (2016). In the eye of the beholder: to make global health estimates useful, make them more socially robust. Global Health Action. 10(sup1). 1266180–1266180. 21 indexed citations
15.
Pisani, Elizabeth. (2014). Indonesia in pieces. Foreign Affairs. 93(4). 142–152. 2 indexed citations
16.
Pisani, Elizabeth, James Whitworth, Basia Żaba, & Carla AbouZahr. (2009). Time for fair trade in research data. The Lancet. 375(9716). 703–705. 29 indexed citations
17.
Catassi, Carlo, Michele Rossini, I M Rätsch, et al.. (1993). Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.. Gut. 34(11). 1515–1519. 104 indexed citations
18.
Scarpelli, Marina, Rodolfo Montironi, Yrjö Collan, et al.. (1989). Malignant glial tumours: prognostic value of quantitative microscopy. min - Minimally Invasive Neurosurgery. 32(5). 135–140. 3 indexed citations
19.
Greca, G. La, S Biasioli, S. Chiaramonte, et al.. (1982). Studies on Brain Density in Hemodialysis and Peritoneal Dialysis. ˜The œNephron journals/Nephron journals. 31(2). 146–150. 34 indexed citations
20.
Greca, G. La, S Biasioli, S. Chiaramonte, et al.. (1982). Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.. PubMed. 20(2). 92–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hala Ghattas Breakdown of academic impact, for papers by Heather Brown Breakdown of academic impact, for papers by Tim Brown Breakdown of academic impact, for papers by Douglas Johnson Breakdown of academic impact, for papers by Alec Miners Breakdown of academic impact, for papers by Martin B Van Der Weyden Breakdown of academic impact, for papers by Kevin L. Schwartz Breakdown of academic impact, for papers by Joanne Yoong Breakdown of academic impact, for papers by Howard Markel Breakdown of academic impact, for papers by Juan Pablo Gutiérrez
Rankless by CCL
2026